Contract Manufacturing
Total Trials
12
As Lead Sponsor
2
As Collaborator
10
Total Enrollment
12,038
NCT00207168
To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine
Phase: Phase 4
Role: Collaborator
Start: Apr 30, 2004
Completion: Dec 31, 2006
NCT00930137
Ruminant Trans Fats and the Risk of Cardiovascular Disease in Women
Phase: N/A
Start: Sep 30, 2009
Completion: Sep 30, 2011
NCT01739153
Effect of Cheese on Cardiovascular Risk
Start: Jan 31, 2013
Completion: Nov 30, 2014
NCT01949259
Rapid Learning for Lung Cancer
Start: Sep 30, 2013
Completion: Aug 31, 2014
NCT02616471
Effect of High Cheese Consumption on Metabolic Syndrome Risk Factors
Start: Feb 28, 2014
Completion: May 31, 2015
NCT02474524
Self-Management and Recovery Technology Psychosocial Intervention Trial
Start: Jan 1, 2015
Completion: Jul 31, 2017
NCT03690791
Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease
Phase: Phase 3
Start: Jan 9, 2019
Completion: Jan 30, 2024
NCT04602481
COVID-19 in People With Primary Ciliary Dyskinesia
Start: May 31, 2020
Completion: May 31, 2030
NCT04997954
EMERALD TRIAL Open Label Extension Study
Start: May 17, 2021
Completion: Jan 31, 2024
NCT04997395
Feasibility of Cannabidiol for the Treatment of Long COVID
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 14, 2022
Completion: Jan 6, 2023
NCT05253417
The CANabidiol Use for RElief of Short Term Insomnia
Start: May 1, 2022
Completion: Jul 7, 2023
NCT07114354
Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease
Start: Aug 18, 2025
Completion: Dec 31, 2026
Loading map...